nevirapine 400 MG 24 HR Extended Release Oral Tablet
- RxCUI
- 1095712
- RxNorm name
- nevirapine 400 MG 24 HR Extended Release Oral Tablet
- Display name
- nevirapine 400 MG 24 HR Extended Release Oral Tablet
- Full name
- nevirapine 400 MG 24 HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | 690da74b-2481-47fc-93ae-8340e0caf0a4 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | 1095712 |
| NEVIRAPINE | NEVIRAPINE | Macleods Pharmaceuticals Limited | 2620b114-f53f-44f1-8708-697e86343090 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | 1095712 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 690da74b-2481-47fc-93ae-8340e0caf0a4 | nevirapine 400 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR nevirapine 400 MG Extended Release Oral Tablet [SCD] · nevirapine 400 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 10 | These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | 20241015 |
| 2620b114-f53f-44f1-8708-697e86343090 | nevirapine 400 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR nevirapine 400 MG Extended Release Oral Tablet [SCD] · nevirapine 400 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | 20240814 |